Log In Sign up
The largest database of trusted experimental protocols

Lamivudine

Manufactured by Gilead Sciences
Visit Supplier

Lamivudine is a laboratory product manufactured by Gilead Sciences. It is a nucleoside reverse transcriptase inhibitor (NRTI) that can be used in research and development applications.

Automatically generated - may contain errors

Lab products found in correlation

Emtricitabine, by Gilead Sciences (3 mentions) Abacavir, by Gilead Sciences (3 mentions) Dolutegravir, by Gilead Sciences (3 mentions) Tenofovir alafenamide, by Gilead Sciences (3 mentions) Tenofovir disoproxil fumarate, by Gilead Sciences (3 mentions) Raltegravir, by Gilead Sciences (3 mentions)

3 protocols using lamivudine

1

Antivirals and HIV Plasmid Protocol

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
The antivirals Emtricitabine (FTC), Tenofovir Disoproxil Fumarate (TDF), Raltegravir (RAL), abacavir (ABC), dolutegravir (DOL), lamivudine (3TC), tenofovir alafenamide (TAF) were a gift from Gilead Sciences or were obtained from pharmacy. HIV p89.6 plasmid DNA was obtained from the NIH AIDS reagent Program. Murine chow diet with antibiotic was purchased from Envigo Teklad Diets. All other materials were purchased from commercially available sources and have been previously described in detail [15 (link)]. All lipids were purchased from Cayman Chemicals (Ann Arbor, MI, USA) and are described in detail in the Supplemental material.
Daskou M., Sharma M., Mu W., Heymans R., Ritou E., Rezek V., Hamid P., Kossyvakis A., Sen Roy S., Grijalva V., Chattopadhyay A., Papesh J., Meriwether D., Kitchen S.G., Fogelman A.M., Reddy S.T, & Kelesidis T. (2021). ApoA-I mimetics favorably impact cyclooxygenase 2 and bioactive lipids that may contribute to cardiometabolic syndrome in chronic treated HIV. Metabolism: clinical and experimental, 124, 154888.
+ Open protocol
+ Expand
2

Antivirals and HIV Plasmid Protocol

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
The antivirals Emtricitabine (FTC), Tenofovir Disoproxil Fumarate (TDF), Raltegravir (RAL), abacavir (ABC), dolutegravir (DOL), lamivudine (3TC), tenofovir alafenamide (TAF) were a gift from Gilead Sciences or were obtained from pharmacy. HIV p89.6 plasmid DNA was obtained from the NIH AIDS reagent Program. Murine chow diet with antibiotic was purchased from Envigo Teklad Diets. All other materials were purchased from commercially available sources and have been previously described in detail [15 (link)]. All lipids were purchased from Cayman Chemicals (Ann Arbor, MI, USA) and are described in detail in the Supplemental material.
Daskou M., Sharma M., Mu W., Heymans R., Ritou E., Rezek V., Hamid P., Kossyvakis A., Sen Roy S., Grijalva V., Chattopadhyay A., Papesh J., Meriwether D., Kitchen S.G., Fogelman A.M., Reddy S.T, & Kelesidis T. (2021). ApoA-I mimetics favorably impact cyclooxygenase 2 and bioactive lipids that may contribute to cardiometabolic syndrome in chronic treated HIV. Metabolism: clinical and experimental, 124, 154888.
+ Open protocol
+ Expand
3

Transgenic Tomato-Derived Antiviral Compounds

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
A concentrate of control transgenic tomatoes (EV) or a concentrate of transgenic tomatoes expressing the 6F peptide (Tg6F) were prepared and added to the diets at 0.06% by weight as described previously [11 (link)]. 4F and 6F peptides were synthesized as previously [14 (link)]. The antivirals Emtricitabine (FTC), Tenofovir Disoproxil Fumarate (TDF), Raltegravir (RAL), abacavir (ABC), dolutegravir (DOL), lamivudine (3TC), tenofovir alafenamide (TAF), FTC were either a generous gift from Gilead Sciences or were obtained from pharmacy. HIV p89.6 plasmid DNA was obtained from the NIH AIDS reagent Program. Murine chow diet with antibiotic was purchased from Envigo Teklad Diets. All other materials were purchased from commercially available sources and have been previously described in detail [24 (link)].
Daskou M., Mu W., Sharma M., Vasilopoulos H., Heymans R., Ritou E., Rezek V., Hamid P., Kossyvakis A., Sen Roy S., Grijalva V., Chattopadhyay A., Kitchen S.G., Fogelman A.M., Reddy S.T, & Kelesidis T. (2022). ApoA-I mimetics reduce systemic and gut inflammation in chronic treated HIV. PLoS Pathogens, 18(1), e1010160.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!